Cite

    Veronica Huber et al.. “Back to simplicity: a four-marker blood cell score to quantify prognostically relevant myeloid cells in melanoma patients.” Journal for immunotherapy of cancer, vol. 9, no. 2, 2021, p. . http://access.bl.uk/ark:/81055/vdc_100127565076.0x000033